Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar-Apr;11(2):106-15.
doi: 10.1370/afm.1466.

Long-term psychosocial consequences of false-positive screening mammography

John Brodersen  1 , Volkert Dirk Siersma
Affiliations

Long-term psychosocial consequences of false-positive screening mammography

John Brodersen et al. Ann Fam Med. 2013 Mar-Apr.

Abstract

Purpose: Cancer screening programs have the potential of intended beneficial effects, but they also inevitably have unintended harmful effects. In the case of screening mammography, the most frequent harm is a false-positive result. Prior efforts to measure their psychosocial consequences have been limited by short-term follow-up, the use of generic survey instruments, and the lack of a relevant benchmark-women with breast cancer.

Methods: In this cohort study with a 3-year follow-up, we recruited 454 women with abnormal findings in screening mammography over a 1-year period. For each woman with an abnormal finding on a screening mammogram (false and true positives), we recruited another 2 women with normal screening results who were screened the same day at the same clinic. These participants were asked to complete the Consequences of Screening in Breast Cancer-a validated questionnaire encompassing 12 psychosocial outcomes-at baseline, 1, 6, 18, and 36 months.

Results: Six months after final diagnosis, women with false-positive findings reported changes in existential values and inner calmness as great as those reported by women with a diagnosis of breast cancer (Δ = 1.15; P = .015; and Δ = 0.13; P = .423, respectively). Three years after being declared free of cancer, women with false-positive results consistently reported greater negative psychosocial consequences compared with women who had normal findings in all 12 psychosocial outcomes (Δ >0 for 12 of 12 outcomes; P <.01 for 4 of 12 outcomes).

Conclusion: False-positive findings on screening mammography causes long-term psychosocial harm: 3 years after a false-positive finding, women experience psychosocial consequences that range between those experienced by women with a normal mammogram and those with a diagnosis of breast cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The distribution of screening results and final diagnosis among the eligible women and these women’s response rates at 5 time points: baseline, 1, 6, 18, and 36 months.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 2
The mean score of each of the 8 psychosocial outcomes, part I of the COS-BC for the 3 screening groups at 5 time points: 0, 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 2
The mean score of each of the 8 psychosocial outcomes, part I of the COS-BC for the 3 screening groups at 5 time points: 0, 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 2
The mean score of each of the 8 psychosocial outcomes, part I of the COS-BC for the 3 screening groups at 5 time points: 0, 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 2
The mean score of each of the 8 psychosocial outcomes, part I of the COS-BC for the 3 screening groups at 5 time points: 0, 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 2
The mean score of each of the 8 psychosocial outcomes, part I of the COS-BC for the 3 screening groups at 5 time points: 0, 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 2
The mean score of each of the 8 psychosocial outcomes, part I of the COS-BC for the 3 screening groups at 5 time points: 0, 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 2
The mean score of each of the 8 psychosocial outcomes, part I of the COS-BC for the 3 screening groups at 5 time points: 0, 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 2
The mean score of each of the 8 psychosocial outcomes, part I of the COS-BC for the 3 screening groups at 5 time points: 0, 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 3
The mean score of each of the 4 psychosocial outcomes, part II of the COS-BC for 2 or 3 of the screening groups at 4 time points: 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 3
The mean score of each of the 4 psychosocial outcomes, part II of the COS-BC for 2 or 3 of the screening groups at 4 time points: 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 3
The mean score of each of the 4 psychosocial outcomes, part II of the COS-BC for 2 or 3 of the screening groups at 4 time points: 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
COS-BC = Consequences of Screening in Breast Cancer.
Figure 3
The mean score of each of the 4 psychosocial outcomes, part II of the COS-BC for 2 or 3 of the screening groups at 4 time points: 1, 6, 18, and 36 months. COS-BC = Consequences of Screening in Breast Cancer.
See this image and copyright information in PMC

Comment in

References

    1. Welch HG. Should I Be Tested for Cancer? Maybe Not and Here’s Why. Los Angeles, CA: University of California Press; 2004
    1. Gøtzsche PC, Hartling OJ, Nielsen M, Brodersen J, Jørgensen KJ. Breast screening: the facts—or maybe not. BMJ. 2009;338:b86. - PubMed
    1. Brodersen J, Jørgensen KJ, Gøtzsche PC. The benefits and harms of screening for cancer with a focus on breast screening. Pol Arch Med Wewn. 2010;120(3):89–94 - PubMed
    1. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. [see comments]. N Engl J Med. 1998;338(16): 1089–1096 - PubMed
    1. Christiansen CL, Wang F, Barton MB, et al. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst. 2000; 92(20):1657–1666 - PubMed

Publication types